Episurf Medical AB (publ) (0QUT.L)

0,7230 -0,3110 (-30,08%) Alla chiusura: 09:25AM BST

Episurf Medical AB (publ)

Karlavägen 60
Stockholm 114 49
Sweden
46 86 12 00 20
https://episurf.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 28

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Pal Ryfors	Chief Executive Officer	4,5M	N/D	1983
Ms. Veronica Wallin	Chief Financial Officer	N/D	N/D	1986
Ms. Katarina Flodström Ph.D.	Chief Operating Officer	N/D	N/D	1975
Mr. Fredrik Zetterberg	Marketing Director	N/D	N/D	1975
Mr. Patrick Jamnik	President of Episurf Medical Inc	N/D	N/D	1983

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient's distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Episurf Medical AB (publ) al 1 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 2; diritti degli azionisti: 4; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.